Anticoagulants in obstetrics
During pregnancy, venous thromboembolic events (VTE) (absolute VTE rates) are relatively low and occur with a frequency of approximately 0.06% or 0.5–2.2 per 1000 deliveries [1–3]. Nevertheless, VTE is one of the key causes of maternal mortality (on top of that, conditionally avoidable). It is belie...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2421 |
Summary: | During pregnancy, venous thromboembolic events (VTE) (absolute VTE rates) are relatively low and occur with a frequency of approximately 0.06% or 0.5–2.2 per 1000 deliveries [1–3]. Nevertheless, VTE is one of the key causes of maternal mortality (on top of that, conditionally avoidable). It is believed that during pregnancy the risk of VTE is increased dramatically - about three to tenfold [4] compared to non-pregnant women, provided that most of the women do not have VTE before pregnancy. According to some authors [5–6], in the postpartum period the risk of VTE is increased 15– to 35-fold compared to age-matched non-pregnant women and remains elevated for 3–6 months after delivery. |
---|---|
ISSN: | 2079-701X 2658-5790 |